← United States · Coverage record
US · SEC FORM 4
HAEMONETICS CORP
HAE · NYSE · CIK 0000313143 · Healthcare · Medical Devices
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
25 Form 4 transaction lines observed in the same window
0 sales · 25 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 9 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-11-10 · KROLL MARK W.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 3,037,763
- Previous report
- 3,424,696
- Avg daily volume
- 569,315
- Days to cover
- 5.3
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | KROLL MARK W | Purchase (P) | Common Stock | 1,400 | USD 70.56 | USD 98,784 | SEC filing ↗ |
| 2020-08-11 | ABERNATHY ROBERT E | Purchase (P) | Common Stock | 4,000 | USD 80.93 | USD 323,720 | SEC filing ↗ |
Form 4 evidence
27 transaction lines in the latest 365-day window; 401 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Zane Ellen M | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | Pomeroy Claire | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | Madaus Martin D | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (27 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Zane Ellen M | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | Pomeroy Claire | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | Madaus Martin D | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | KROLL MARK W | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | Johnson Lloyd Emerson | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | COYLE MICHAEL J | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | Bryant Diane M | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-07-24 | ABERNATHY ROBERT E | Award / grant (A) | Common Stock | 2,538 | USD — | USD — | SEC filing ↗ |
| 2026-06-05 | Miller Laurie A. | Tax withholding (F) | Common Stock | 313 | USD 71.28 | USD 22,311 | SEC filing ↗ |
| 2026-06-05 | Maunsell Farris Maryanne | Tax withholding (F) | Common Stock | 259 | USD 71.28 | USD 18,462 | SEC filing ↗ |
| 2026-05-15 | Simon, Christopher | Tax withholding (F) | Common Stock | 9,681 | USD 56.29 | USD 544,943 | SEC filing ↗ |
| 2026-05-15 | Simon, Christopher | Award / grant (A) | Common Stock | 78,344 | USD — | USD — | SEC filing ↗ |
| 2026-05-15 | Miller Laurie A. | Tax withholding (F) | Common Stock | 948 | USD 56.29 | USD 53,363 | SEC filing ↗ |
| 2026-05-15 | Miller Laurie A. | Award / grant (A) | Common Stock | 13,323 | USD — | USD — | SEC filing ↗ |
| 2026-05-15 | Maunsell Farris Maryanne | Tax withholding (F) | Common Stock | 197 | USD 56.29 | USD 11,089 | SEC filing ↗ |
| 2026-05-15 | Maunsell Farris Maryanne | Award / grant (A) | Common Stock | 2,220 | USD — | USD — | SEC filing ↗ |
| 2026-05-15 | Galvin Roy | Tax withholding (F) | Common Stock | 879 | USD 56.29 | USD 49,479 | SEC filing ↗ |
| 2026-05-15 | Galvin Roy | Award / grant (A) | Common Stock | 27,535 | USD — | USD — | SEC filing ↗ |
| 2026-05-15 | DArecca James | Tax withholding (F) | Common Stock | 2,505 | USD 56.29 | USD 141,006 | SEC filing ↗ |
| 2026-05-15 | DArecca James | Award / grant (A) | Common Stock | 29,312 | USD — | USD — | SEC filing ↗ |
| 2026-05-15 | Chan Frank | Tax withholding (F) | Common Stock | 546 | USD 56.29 | USD 30,734 | SEC filing ↗ |
| 2026-05-15 | Chan Frank | Award / grant (A) | Common Stock | 27,535 | USD — | USD — | SEC filing ↗ |
| 2026-05-15 | Basil Michelle L | Tax withholding (F) | Common Stock | 2,913 | USD 56.29 | USD 163,973 | SEC filing ↗ |
| 2026-05-15 | Basil Michelle L | Award / grant (A) | Common Stock | 28,424 | USD — | USD — | SEC filing ↗ |
| 2026-05-01 | DArecca James | Tax withholding (F) | Common Stock | 655 | USD 59.26 | USD 38,815 | SEC filing ↗ |
| 2025-11-10 | KROLL MARK W | Purchase (P) | Common Stock | 1,400 | USD 70.56 | USD 98,784 | SEC filing ↗ |
| 2025-10-31 | Galvin Roy | Tax withholding (F) | Common Stock | 145 | USD 50.01 | USD 7,251 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | HAE |
| CIK | 0000313143 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 401 transaction lines from 2020-03-06 to 2026-07-24 2 P purchase lines · 135 S sale lines · 264 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.